148 related articles for article (PubMed ID: 25601452)
1. HER3 expression in primary colorectal cancer including corresponding metastases in lymph node and liver.
Lédel F; Stenstedt K; Hallström M; Ragnhammar P; Edler D
Acta Oncol; 2015 Apr; 54(4):480-6. PubMed ID: 25601452
[TBL] [Abstract][Full Text] [Related]
2. HER3 expression in patients with primary colorectal cancer and corresponding lymph node metastases related to clinical outcome.
Lédel F; Hallström M; Ragnhammar P; Öhrling K; Edler D
Eur J Cancer; 2014 Feb; 50(3):656-62. PubMed ID: 24300455
[TBL] [Abstract][Full Text] [Related]
3. EGFR, HER2 and HER3 expression in primary colorectal carcinomas and corresponding metastases: Implications for targeted radionuclide therapy.
Wei Q; Shui Y; Zheng S; Wester K; Nordgren H; Nygren P; Glimelius B; Carlsson J
Oncol Rep; 2011 Jan; 25(1):3-11. PubMed ID: 21109951
[TBL] [Abstract][Full Text] [Related]
4. Expression of EGFR, Her2 predict lymph node metastasis (LNM)-associated metastasis in colorectal cancer.
Lu Y; Jingyan G; Baorong S; Peng J; Xu Y; Cai S
Cancer Biomark; 2012; 11(5):219-26. PubMed ID: 23220854
[TBL] [Abstract][Full Text] [Related]
5. The expression of CYP2W1 in colorectal primary tumors, corresponding lymph node metastases and liver metastases.
Stenstedt K; Hallstrom M; Lédel F; Ragnhammar P; Ingelman-Sundberg M; Johansson I; Edler D
Acta Oncol; 2014 Jul; 53(7):885-91. PubMed ID: 24625228
[TBL] [Abstract][Full Text] [Related]
6. EGFR, HER2 and HER3 expression in esophageal primary tumours and corresponding metastases.
Wei Q; Chen L; Sheng L; Nordgren H; Wester K; Carlsson J
Int J Oncol; 2007 Sep; 31(3):493-9. PubMed ID: 17671674
[TBL] [Abstract][Full Text] [Related]
7. Variability in HER2 expression between primary colorectal cancer and corresponding metastases.
Shan L; Lv Y; Bai B; Huang X; Zhu H
J Cancer Res Clin Oncol; 2018 Nov; 144(11):2275-2281. PubMed ID: 30203148
[TBL] [Abstract][Full Text] [Related]
8. Differences in AgNOR quantity between colorectal cancer and corresponding metastases: are they useful for prognostic purposes?
Giuffrè G; Barresi G; Speciale G; Sarnelli R; Gioffrè Florio MA; Tuccari G
Eur J Histochem; 1997; 41(2):111-8. PubMed ID: 9271703
[TBL] [Abstract][Full Text] [Related]
9. EGFR, HER2, and HER3 protein expression in paired primary tumor and lymph node metastasis of colorectal cancer.
Ye P; Li F; Wei Y; Zhang Y; Cui J; Dai R; Chen H; Xie J; Cai P
Sci Rep; 2022 Jul; 12(1):12894. PubMed ID: 35902718
[TBL] [Abstract][Full Text] [Related]
10. Epidermal growth factor receptor (EGFR) mRNA levels and protein expression levels in primary colorectal cancer and corresponding liver metastases.
Kuramochi H; Hayashi K; Nakajima G; Kamikozuru H; Yamamoto M; Danenberg KD; Danenberg PV
Cancer Chemother Pharmacol; 2010 Apr; 65(5):825-31. PubMed ID: 19701635
[TBL] [Abstract][Full Text] [Related]
11. Detection of thymidylate synthase expression in lymph node metastases of colorectal cancer can improve the prognostic information.
Ohrling K; Edler D; Hallström M; Ragnhammar P; Blomgren H
J Clin Oncol; 2005 Aug; 23(24):5628-34. PubMed ID: 16009948
[TBL] [Abstract][Full Text] [Related]
12. Bone marrow-derived mesenchymal stem cells promote colorectal cancer progression through paracrine neuregulin 1/HER3 signalling.
De Boeck A; Pauwels P; Hensen K; Rummens JL; Westbroek W; Hendrix A; Maynard D; Denys H; Lambein K; Braems G; Gespach C; Bracke M; De Wever O
Gut; 2013 Apr; 62(4):550-60. PubMed ID: 22535374
[TBL] [Abstract][Full Text] [Related]
13. EGFR, HER2, and HER3 expression in laryngeal primary tumors and corresponding metastases.
Wei Q; Sheng L; Shui Y; Hu Q; Nordgren H; Carlsson J
Ann Surg Oncol; 2008 Apr; 15(4):1193-201. PubMed ID: 18172732
[TBL] [Abstract][Full Text] [Related]
14. Her2 amplification is significantly more frequent in lymph node metastases from urothelial bladder cancer than in the primary tumours.
Fleischmann A; Rotzer D; Seiler R; Studer UE; Thalmann GN
Eur Urol; 2011 Aug; 60(2):350-7. PubMed ID: 21640482
[TBL] [Abstract][Full Text] [Related]
15. [Expression of metallothionein and FasL in colorectal cancer and its clinical significance].
Li SY; Yu B; An P; Zuo FY; Cai HY
Zhonghua Wai Ke Za Zhi; 2005 Sep; 43(17):1118-20. PubMed ID: 16194308
[TBL] [Abstract][Full Text] [Related]
16. Clinical relevance of transforming growth factor alpha, epidermal growth factor receptor, p53, and Ki67 in colorectal liver metastases and corresponding primary tumors.
De Jong KP; Stellema R; Karrenbeld A; Koudstaal J; Gouw AS; Sluiter WJ; Peeters PM; Slooff MJ; De Vries EG
Hepatology; 1998 Oct; 28(4):971-9. PubMed ID: 9755233
[TBL] [Abstract][Full Text] [Related]
17. [Hepatic lymph node involvement in patients with synchronous multiple liver metastases of colorectal cancer].
Ishibashi K; Ohsawa T; Yokoyama M; Ishizuka N; Miyazaki T; Nakada H; Gonda T; Ishida H
Gan To Kagaku Ryoho; 2006 Nov; 33(12):1834-7. PubMed ID: 17212121
[TBL] [Abstract][Full Text] [Related]
18. nm23 protein expression in colorectal carcinoma metastasis in regional lymph nodes and the liver.
Sarris M; Lee CS
Eur J Surg Oncol; 2001 Mar; 27(2):170-4. PubMed ID: 11289754
[TBL] [Abstract][Full Text] [Related]
19. Biomarker expression and St Gallen molecular subtype classification in primary tumours, synchronous lymph node metastases and asynchronous relapses in primary breast cancer patients with 10 years' follow-up.
Falck AK; Bendahl PO; Chebil G; Olsson H; Fernö M; Rydén L
Breast Cancer Res Treat; 2013 Jul; 140(1):93-104. PubMed ID: 23807420
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical variability of epidermal growth factor receptor (EGFR) in liver metastases from colonic carcinomas.
Bralet MP; Paule B; Falissard B; Adam R; Guettier C
Histopathology; 2007 Jan; 50(2):210-6. PubMed ID: 17222249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
